Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Cannabidiol for Anxiety
NCT02548559Phase 2Completed
- Start
- Aug 2018
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in anxiety disorder. Started Aug 2018; status: completed.
02
Drugs
cannabidiol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02548559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548559.